HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[ Intermittent, longterm polychemotherapy in combination with radical operation of bronchial carcinoma (author's transl)].

Abstract
A preliminary evaluation of a randomized, prospective clinical study of combined polychemotherapy in bronchial carcinoma is presented. The comparison of survival-curves shows a positive tendency in favor of the treatment and justifies the continuation and extension of the study. The data presented are based on the findings of 106 patients who underwent radical surgical operations due to bronchial carcinoma and of 114 patients as a comparison who in addition received aftertreatment with high doses of cytostatics applied intermittently. The importance of the influence of the clinical symptoms on the prognosis and on the effect of the Chemotherapy is emphasized.
AuthorsN Pridun, K Karrer, H Denck
JournalZentralblatt fur Chirurgie (Zentralbl Chir) Vol. 101 Issue 10 Pg. 602-7 ( 1976) ISSN: 0044-409X [Print] Germany
Vernacular TitleIntermittierende, langdauernde Polychemotherapie nach Radikaloperation des Bronchuskarzinoms
PMID952109 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antineoplastic Agents
  • Vinblastine
  • Cyclophosphamide
  • Methotrexate
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Bronchial Neoplasms (drug therapy, surgery)
  • Cyclophosphamide (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Postoperative Complications (drug therapy)
  • Time Factors
  • Vinblastine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: